11-74493431-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 2P and 13B. PM2BP4_StrongBP6_Very_StrongBP7
The NM_001144869.3(LIPT2):c.273C>T(p.Phe91=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000131 in 1,505,956 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00014 ( 1 hom., cov: 34)
Exomes 𝑓: 0.00013 ( 0 hom. )
Consequence
LIPT2
NM_001144869.3 synonymous
NM_001144869.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.12
Genes affected
LIPT2 (HGNC:37216): (lipoyl(octanoyl) transferase 2) This gene encodes a mitochondrial protein that catalyzes the transfer of octanoic acid to lipoate-dependent enzymes such as octanoyl-ACP. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 11-74493431-G-A is Benign according to our data. Variant chr11-74493431-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 1601557.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.12 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LIPT2 | NM_001144869.3 | c.273C>T | p.Phe91= | synonymous_variant | 1/2 | ENST00000310109.5 | |
LIPT2-AS1 | NR_171028.1 | n.52G>A | non_coding_transcript_exon_variant | 1/2 | |||
LIPT2 | NM_001329941.2 | c.273C>T | p.Phe91= | synonymous_variant | 1/2 | ||
LIPT2 | NM_001329942.2 | c.237+36C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LIPT2 | ENST00000310109.5 | c.273C>T | p.Phe91= | synonymous_variant | 1/2 | 2 | NM_001144869.3 | P1 | |
LIPT2-AS1 | ENST00000526036.1 | n.66G>A | non_coding_transcript_exon_variant | 1/2 | 1 | ||||
LIPT2 | ENST00000528085.1 | c.181+36C>T | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152214Hom.: 1 Cov.: 34
GnomAD3 genomes
AF:
AC:
23
AN:
152214
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00142 AC: 143AN: 100900Hom.: 0 AF XY: 0.000977 AC XY: 55AN XY: 56306
GnomAD3 exomes
AF:
AC:
143
AN:
100900
Hom.:
AF XY:
AC XY:
55
AN XY:
56306
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000130 AC: 176AN: 1353630Hom.: 0 Cov.: 42 AF XY: 0.000115 AC XY: 77AN XY: 667412
GnomAD4 exome
AF:
AC:
176
AN:
1353630
Hom.:
Cov.:
42
AF XY:
AC XY:
77
AN XY:
667412
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000144 AC: 22AN: 152326Hom.: 1 Cov.: 34 AF XY: 0.000161 AC XY: 12AN XY: 74490
GnomAD4 genome
AF:
AC:
22
AN:
152326
Hom.:
Cov.:
34
AF XY:
AC XY:
12
AN XY:
74490
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Dec 13, 2021 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at